Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
180 Life Sciences Corp. - Common Stock
(NQ:
ATNF
)
1.860
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.860
Bid (Size)
1.920 (1)
Ask (Size)
1.990 (2)
Prev. Close
1.860
Today's Range
1.860 - 1.860
52wk Range
1.160 - 17.75
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
December 12, 2024
Via
ACCESSWIRE
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
December 04, 2024
Via
ACCESSWIRE
Performance
YTD
-52.41%
-52.41%
1 Month
-17.33%
-17.33%
3 Month
N/A
N/A
6 Month
+24.83%
+24.83%
1 Year
-48.26%
-48.26%
More News
Read More
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
October 31, 2024
Via
ACCESSWIRE
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
October 29, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's Intraday Session
October 25, 2024
Via
Benzinga
180 Life Sciences Corp. - Corporate Updates
October 03, 2024
Via
ACCESSWIRE
ATNF Stock Earnings: 180 Life Sciences Reported Results for Q2 2024
August 12, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
October 17, 2024
Via
Benzinga
Dow Jumps Over 100 Points; Alcoa Profit Beats Estimates
October 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 17, 2024
Via
Benzinga
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 16, 2024
Via
Benzinga
Nasdaq Moves Higher; Morgan Stanley Profit Beats Estimates
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 16, 2024
Via
Benzinga
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
October 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
October 16, 2024
Via
Benzinga
180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform
October 16, 2024
Via
ACCESSWIRE
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Says Recent Acquisition to Help Capitalize on ‘Tremendous’ Potential in iGaming Market
October 09, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
October 09, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — 180 Life Sciences Corp. (NASDAQ: ATNF) Provides Update on Strategic Corporate Initiatives
October 03, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
BioMedNewsBreaks — 180 Life Sciences Corp. (NASDAQ: ATNF) Appoints Omar Jimenez as Chief Financial Officer
September 13, 2024
Via
Investor Brand Network
180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer
September 12, 2024
From
180 Life Sciences Corp.
Via
GlobeNewswire
Why Modular Medical Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
September 05, 2024
Via
Benzinga
BioMedNewsBreaks — 180 Life Sciences Corp. (NASDAQ: ATNF) Reports on Human Clinical Trial Evaluating Solid Formulation of CBD with Enhanced Oral Uptake
July 30, 2024
Via
Investor Brand Network
180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
July 30, 2024
From
180 Life Sciences Corp.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.